Analysts Offer Insights on Healthcare Companies: Senseonics Holdings (SENS) and BioNTech SE (BNTX)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Senseonics Holdings (SENS – Research Report) and BioNTech SE (BNTX – Research Report) with bullish sentiments.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Senseonics Holdings (SENS)
In a report released today, Josh Jennings from TD Cowen reiterated a Buy rating on Senseonics Holdings, with a price target of $15.00. The company’s shares closed last Tuesday at $5.98.
According to TipRanks.com, Jennings is a 4-star analyst with an average return of
Senseonics Holdings has an analyst consensus of Moderate Buy, with a price target consensus of $18.70, implying a 196.8% upside from current levels. In a report issued on March 3, Mizuho Securities also maintained a Buy rating on the stock.
See the top stocks recommended by analysts >>
BioNTech SE (BNTX)
Clear Street analyst William Maughan reiterated a Buy rating on BioNTech SE today and set a price target of $167.00. The company’s shares closed last Tuesday at $84.47, close to its 52-week low of $76.53.
According to TipRanks.com, Maughan is a 5-star analyst with an average return of
Currently, the analyst consensus on BioNTech SE is a Strong Buy with an average price target of $141.44, implying a 70.8% upside from current levels. In a report issued on February 23, Morgan Stanley also maintained a Buy rating on the stock with a $134.00 price target.
